Scl-70 antigen stability and its effect on antibody detection in scleroderma

Area of Science:

• Immunology
• Molecular Biology
• Rheumatology

Background:

• Scleroderma is an autoimmune disease characterized by connective tissue hardening.
• Scl-70 antibodies are a significant biomarker in scleroderma diagnosis.
• Previous methods for Scl-70 antibody detection showed variable sensitivity.

Purpose of the Study:

• To compare the diagnostic efficacy of gel precipitation and immunoblot methods for Scl-70 antibody detection.
• To characterize the molecular properties of the Scl-70 antigen.
• To investigate the relationship between Scl-70 antigen molecular forms and DNA binding.

Main Methods:

• Examined 38 scleroderma patients, 10 systemic lupus erythematosus patients, and 10 healthy controls.
• Utilized gel precipitation and immunoblot techniques for Scl-70 antibody detection.
• Performed immunoblot analysis on Scl-70 antigen extracted from rabbit and calf thymus using varying NaCl concentrations.

Main Results:

• The immunoblot method identified Scl-70 antibodies in 55% of scleroderma patients, compared to 40-42% with gel precipitation.
• Immunoblot analysis revealed Scl-70 antigen components of 100, 86, 80, and 70 kDa with high salt extraction.
• Lower salt extraction and calf thymus antigen primarily yielded a 70 kDa band, suggesting differential DNA binding affinities.

Conclusions:

• The immunoblot method offers superior sensitivity for detecting Scl-70 antibodies in scleroderma.
• The Scl-70 antigen exists in various molecular forms with differing affinities for nuclear DNA.
• Differential DNA binding and potential proteolytic digestion may explain the observed molecular heterogeneity of the Scl-70 antigen.